.... Herzog said ongoing studies, including the NCIC CTG OV.21 and MRC-UK
ICON8 trials, are hoping to add further clarity to the use of
neoadjuvant chemotherapy in ovarian cancer....
0
comments
:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.